What is Wedbush’s Forecast for VYGR FY2029 Earnings?
Investment analysts at Wedbush issued their FY2029 earnings per share estimates for Voyager Therapeutics in a report released on Tuesday, February 11th. Wedbush analyst Y. Zhong expects that the ...
Despite tariff fears European stocks have outperformed Wall Street this year. Here's why UBS thinks that will continue.
In addition, further weakness in the euro - UBS sees it falling to $0.99 by the end of 2025 - would be consistent with improving earnings revisions. A 10% fall in the euro may increase European ...
Fluence Energy (NASDAQ:FLNC) Downgraded to Market Perform Rating by BMO Capital Markets
BMO Capital Markets downgraded shares of Fluence Energy (NASDAQ:FLNC – Free Report) from an outperform rating to a market perform rating in a research note released on Tuesday morning, MarketBeat.com ...
Global Payments Inc. (NYSE:GPN) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 13, 2025 Global Payments Inc. misses on earnings expectations. Reported EPS is ...
European Defence Union For Strength, Peace And Freedom: A Call For A Stronger, Autonomous And Competitive Europe
On the occasion of the 61st Munich Security conference (MSC), leading European policymakers, business leaders and security experts have presented the Munich Declaration 2025 - a bold vision for ...
Stifel Nicolaus Remains a Buy on Lululemon Athletica (LULU)
Stifel Nicolaus analyst Jim Duffy reiterated a Buy rating on Lululemon Athletica (LULU – Research Report) today and set a price target of ...
UBS Keeps Their Buy Rating on Hermes International (HESAF)
UBS analyst Zuzanna Pusz maintained a Buy rating on Hermes International (HESAF – Research Report) today and set a price target of €2,475.00.